Overview
WAVi develops non-invasive neuromodulation devices designed to treat neurological and psychiatric conditions through targeted brain stimulation. The company's technology platform focuses on delivering therapeutic interventions with enhanced precision and patient outcomes.
More in Neurotechnology
Latest industry news
Neuvotion Brings Brain-Computer and Brain-Body Interface Technologies to Market as Nature Medicine Study Lands
2026-07-28 · Product
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
2026-07-27 · Policy
BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets
2026-07-26 · Funding
ReVision Implant Secures €4 Million to Advance Next-Generation Visual Neuroprosthetics
2026-07-25 · Funding
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →